Merck & Co., Inc. (6MK.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
At close: 07:41PM CEST
| Previous Close | 116.80 |
| Open | 115.20 |
| Bid | 115.40 x 100000 |
| Ask | 115.40 x 100000 |
| Day's Range | 115.20 - 116.40 |
| 52 Week Range | 90.70 - 123.20 |
| Volume | |
| Avg. Volume | 312 |
| Market Cap | 293.567B |
| Beta (5Y Monthly) | 0.40 |
| PE Ratio (TTM) | 139.04 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 2.84 (2.46%) |
| Ex-Dividend Date | Jun 17, 2024 |
| 1y Target Est | N/A |
- Simply Wall St.
Merck (NYSE:MRK) Seems To Use Debt Quite Sensibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
- Reuters
Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports
Merck has said it's in the market for deals of up to around $15 billion as it plans ways to deal with a loss of revenue from its aging cancer immunotherapy Keytruda.
- Investing.com
Merck nears $1.3 bln takeover of Eyebiotech- WSJ
Investing.com-- Merck&Company Inc (NYSE:MRK) is close to entering a $1.3 billion deal to buy Eyebiotech, granting the pharmaceutical giant entry into the rapidly growing eyecare market, the Wall Street Journal reported on Tuesday.
© 2024 Yahoo. All rights reserved.